Search Results - "Zheng, Yonglan"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer by Hardeman, Ashley A, Han, Yoo Jane, Grushko, Tatyana A, Mueller, Jeffrey, Gomez, Maria J, Zheng, Yonglan, Olopade, Olufunmilayo I

    Published in PloS one (24-06-2022)
    “…Maternal embryonic leucine-zipper kinase (MELK) regulates cell cycle progression and is highly expressed in many cancers. The molecular mechanism of MELK…”
    Get full text
    Journal Article
  7. 7

    Population-dependent Intron Retention and DNA Methylation in Breast Cancer by Kim, Dongwook, Shivakumar, Manu, Han, Seonggyun, Sinclair, Michael S, Lee, Young-Ji, Zheng, Yonglan, Olopade, Olufunmilayo I, Kim, Dokyoon, Lee, Younghee

    Published in Molecular cancer research (01-03-2018)
    “…Regulation of gene expression by DNA methylation in gene promoter regions is well studied; however, the effects of methylation in the gene body (exons and…”
    Get full text
    Journal Article
  8. 8

    LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications by Han, Yoo Jane, Boatman, Sonja M., Zhang, Jing, Du, Xinxin C., Yeh, Albert C., Zheng, Yonglan, Mueller, Jeffrey, Olopade, Olufunmilayo I.

    Published in Scientific reports (22-10-2018)
    “…Long-noncoding RNAs (lncRNAs) have been shown to participate in oncogenesis across a variety of cancers and may represent novel therapeutic targets. However,…”
    Get full text
    Journal Article
  9. 9

    Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer by Han, Yoo-Jeong, Zhang, Jing, Zheng, Yonglan, Huo, Dezheng, Olopade, Olufunmilayo I

    Published in PloS one (02-11-2016)
    “…Genome wide association studies (GWAS) have identified low penetrance and high frequency single nucleotide polymorphisms (SNPs) that contribute to genetic…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients by Fackenthal, James D., Zhang, Jing, Zhang, Bifeng, Zheng, Yonglan, Hagos, Fitsum, Burrill, Devin R., Niu, Qun, Huo, Dezheng, Sveen, Walmy E., Ogundiran, Temidayo, Adebamowo, Clemet, Odetunde, Abayomi, Falusi, Adeyinka G., Olopade, Olufunmilayo I.

    Published in International journal of cancer (01-09-2012)
    “…Inherited mutations in the BRCA1 and BRCA2 genes are the strongest genetic predictors of breast cancer and are the primary causes of familial breast/ovarian…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry by Wang, Shengfeng, Zheng, Yonglan, Ogundiran, Temidayo O, Ojengbede, Oladosu, Zheng, Wei, Nathanson, Katherine L, Nemesure, Barbara, Ambs, Stefan, Olopade, Olufunmilayo I, Huo, Dezheng

    “…Pancreatic cancer mutation signatures closely resemble breast cancer, suggesting that both cancers may have common predisposition mechanisms that may include…”
    Get full text
    Journal Article
  16. 16

    Novel germline PALB2 truncating mutations in African American breast cancer patients by Zheng, Yonglan, Zhang, Jing, Niu, Qun, Huo, Dezheng, Olopade, Olufunmilayo I.

    Published in Cancer (01-03-2012)
    “…BACKGROUND: It has been demonstrated that the partner and localizer of breast cancer 2 (PALB2) acts as a bridging molecule between the breast cancer 1 (BRCA1)…”
    Get full text
    Journal Article
  17. 17

    Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter by Poli, Elizabeth, Zhang, Jing, Nwachukwu, Chika, Zheng, Yonglan, Adedokun, Babatunde, Olopade, Olufunmilayo I, Han, Yoo-Jeong

    Published in PloS one (05-11-2015)
    “…Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer by Zheng, Yonglan, Zhang, Jing, Hope, Kisha, Niu, Qun, Huo, Dezheng, Olopade, Olufunmilayo I.

    Published in Breast cancer research and treatment (01-12-2010)
    “…It has been reported that one biallelic missense mutation in the RAD51C gene was found in a Fanconi anemia-like disorder and six monoallelic pathogenic…”
    Get full text
    Journal Article
  20. 20

    Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry by Zhang, Jing, Fackenthal, James D., Zheng, Yonglan, Huo, Dezheng, Hou, Ningqi, Niu, Qun, Zvosec, Cecilia, Ogundiran, Temidayo O., Hennis, Anselm J., Leske, Maria Cristina, Nemesure, Barbara, Wu, Suh-Yuh, Olopade, Olufunmilayo I.

    Published in Breast cancer research and treatment (01-07-2012)
    “…Recurrent mutations constituted nearly three quarters of all BRCA1 mutations and almost half of all BRCA2 mutations identified in the first cohort of the…”
    Get full text
    Journal Article